Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AbbVie Inc. (ABBV)

77.61   -0.64 (-0.82%) 06-19 16:01
Open: 78.88 Pre. Close: 78.65
High: 79.2 Low: 77.01
Volume: 4,413,830 Market Cap: 114733M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 78.558 - 79.107 79.107 - 79.528
Low: 75.839 - 76.591 76.591 - 77.169
Close: 76.585 - 77.598 77.598 - 78.375

Technical analysis

as of: 2019-06-19 4:28:59 PM
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 91.94     One year: 95.48
Support: Support1: 73.81    Support2: 61.41
Resistance: Resistance1: 78.72    Resistance2: 81.75
Pivot: 77.61
Moving Average: MA(5): 78.43     MA(20): 78.15
MA(100): 79.44     MA(250): 86.38
MACD: MACD(12,26): -0.21     Signal(9): -0.32
Stochastic oscillator: %K(14,3): 75.38     %D(3): 73.33
RSI: RSI(14): 45.08
52-week: High: 100.23  Low: 73.81  Change(%): -21.0
Average Vol(K): 3-Month: 511933  10-Days: 411884

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ABBV has closed below upper band by 49.8%. Bollinger Bands are 41.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to ABBV's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 19 Jun 2019 13:30:25 Z
Is Abbott Laboratories a Buy?

Tue, 18 Jun 2019 00:29:59 Z
Bayer to Invest 5 Billion Euros in Weedkiller Research

Mon, 17 Jun 2019 23:33:00 Z
J&J's (JNJ) Tremfya Meets Goal in Psoriatic Arthritis Study

Mon, 17 Jun 2019 23:32:52 Z
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know

Mon, 17 Jun 2019 21:29:43 Z
Novartis (NVS) Announces Promising Data on Tasigna & Hyrimoz

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 1478.33
Shares Float (M) 1476.79
% Held by Insiders
% Held by Institutions
Shares Short (K) 27576
Shares Short P. Month (K)

Stock Financials

EPS 7.910
EPS Est. Current Year 5.530
EPS Est. Next Year 6.560
EPS Est. Next Quarter 1.440
Forward EPS 8.888
Book Value (p.s.) 39.310
PEG Ratio 1.16
Profit Margin 16.68
Operating Margin 37.13
Return on Assets (ttm) 8.9
Return on Equity (ttm) -232.3
Qtrly Rev. Growth -1.3
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth -11.70
Operating Cash Flow (M) 13800.00
Levered Free Cash Flow (M) 11140.00

Stock Valuations

P/E 9.81
P/E Growth Ratio -0.01
P/BV 1.97
P/S 5325804544.00
P/CF 8.32

Dividends & Splits

Dividend 5.528
Dividend Yield 0.07
Dividend Pay Date 2019-05-15
Ex-Dividend Date 2019-04-12
Forward Dividend 4.280
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.